1例肝细胞肝癌甲状腺转移罕见病例报道与文献回顾

doi:10.6040/j.issn.1671-7554.0.2021.0174

摘要/Abstract

中图分类号:

R736.1

柴佳威,朱坤兵,张华伟,崔凤云,王甜甜,田兴松. 1例肝细胞肝癌甲状腺转移罕见病例报道与文献回顾[J]. 山东大学学报 (医学版), 2021, 59(3): 120-124.

[1] Nixon IJ, Coca-Pelaz A, Kaleva AI, et al. Metastasis to the thyroid gland: a critical review[J]. Ann Surg Oncol, 2017, 24(6): 1533-1539.
[2] Nixon IJ, Whitcher M, Glick J, et al. Surgical management of metastases to the thyroid gland[J]. Ann Surg Oncol, 2011, 18(3): 800-804.
[3] Papi G, Fadda G, Corsello SM, et al. Metastases to the thyroid gland: prevalence, clinicopathological aspects and prognosis: a 10-year experience[J]. Clin Endocrinol(Oxf), 2007, 66(4): 565-571.
[4] Wood K, Vini L, Harmer C. Metastases to the thyroid gland: the Royal Marsden experience[J]. Eur J Surg Oncol, 2004, 30(6): 583-588.
[5] Chung AY, Tran TB, Brumund KT, et al. Metastases to the thyroid: a review of the literature from the last decade[J]. Thyroid, 2012, 22(3): 258-268.
[6] 陆录, 钦伦秀. 美国癌症联合委员会肝癌分期系统(第8版)更新解读[J]. 中国实用外科杂志, 2017, 37(2): 141-145. LU Lu, QIN Lunxiu. Interpretations on the updates of AJCC Cancer Staging Manual 8th edition for hepatocellular carcinoma [J]. Chinese Journal of Practical Surgery, 2017, 37(2): 141-145.
[7] Kim TY, Kim WB, Gong G, et al. Metastasis to the thyroid diagnosed by fine-needle aspiration biopsy[J]. Clin Endocrinol(Oxf), 2005, 62(2): 236-241.
[8] Lin JD, Weng HF, Ho YS. Clinical and pathological characteristics of secondary thyroid cancer[J]. Thyroid, 1998, 8(2): 149-153.
[9] Elliott RH, Frantz VK. Metastatic carcinoma masquerading as primary thyroid cancer: a report of authors 14 cases[J]. Ann Surg, 1960, 151(4): 551-561.
[10] Mirallié E, Rigaud J, Mathonnet M, et al. Management and prognosis of metastases to the thyroid gland[J]. J Am Coll Surg, 2005, 200(2): 203-207.
[11] Yamada H, Hasegawa Y, Mitsudomi T, et al. Neuroendocrine tumor metastasis to the thyroid gland[J]. Int J Clin Oncol, 2007, 12(1): 63-67.
[12] 张树民,曾昭冲,孙菁,等. 肝细胞肝癌肺转移的预后因素分析[J]. 实用肿瘤杂志, 2005, 20(5): 395-400. ZHANG Shumin, ZENG Zhaochong, SUN Jing, et al. Prognostic analysis of pulmonary matastases form hepatocellular carcinoma [J]. Journal of Practical Oncology, 2005, 20(5): 395-400.
[13] Masuda T, Fukuya T, Ono M, et al. Thyroid metastasis from hepatocellular carcinoma as an initial presentation: a case report[J]. Radiat Med, 2001, 19(1): 43-46.
[14] Silva IS de Souza e, Gonzáles AM, Linhares MM, et al. Long-term follow-up after resection of thyroid metastases from hepatocellular carcinoma in noncirrhotic liver[J]. Arq Bras Endocrinol Metabol, 2013, 57(4): 327-331.
[15] Liang HH, Wu CH, Tam KW, et al. Thyroid metastasis in a patient with hepatocellular carcinoma: case report and review of literature[J]. World J Surg Oncol, 2007, 5(1): 144. doi: 10.1186/1477-7819-5-144.
[16] Toshima T, Taketomi A, Shirabe K, et al. Solitary asymptomatic thyroid metastasis from hepatocellular carcinoma detected by FDG-PET/CT[J]. Case Rep Gastroenterol, 2010, 4(2): 279-285.
[17] Park JY, Yi SY, Kwon T, et al. Sonographic diagnosis of thyroid metastasis from hepatocellular carcinoma[J]. J Clin Ultrasound, 2019, 47(1): 44-46.
[18] Kim HK, Kim SS, Oak CY, et al. Diffuse metastasis to the thyroid: unique ultrasonographic finding and clinical correlation[J]. J Korean Med Sci, 2014, 29(6): 818-824.
[19] Yin H, Luo R, Xiu Y, et al. Thyroid metastasis from hepatocellular carcinoma visualized by ¹⁸F-FDG PET/CT imaging[J]. Clin Nucl Med, 2018, 43(12): e455-e457. doi: 10.1097/RLU.0000000000002281.
[20] Nakhjavani MK, Gharib H, Goellner JR, et al. Metastasis to the thyroid gland. A report of 43 cases[J]. Cancer, 1997, 79(3): 574-578.
[21] Chung AY, Tran TB, Brumund KT, et al. Metastases to the thyroid: a review of the literature from the last decade[J]. Thyroid, 2012, 22(3): 258-268.
[22] 阳宇, 杜晓华, 刘影, 等. 甲状腺乳头状癌中B-raf基因V600E突变的检测方法对比分析[J]. 临床与实验病理学杂志, 2017, 33(7): 815-816.
[23] 张红梅, 周红燕, 汪佩, 等. 甲状腺癌基因检测在甲状腺结节早期诊断中的临床应用[J]. 实用医学杂志, 2018, 34(6): 970-973. ZHANG Hongmei, ZHOU Hongyan, WANG Pei, et al. Clinical application of thyroid cancer gene detection in early diagnosis of thyroid nodules[J]. The Journal of Practical Medcine, 2018, 34(6): 970-973.
[24] Duggal NM, Horattas MC. Metastatic renal cell carcinoma to the thyroid gland.[J]. Endocr Pract, 2008, 14(8): 1040-1046.
[25] Cichoń S, Anielski R, Konturek A, et al. Metastases to the thyroid gland: seventeen cases operated on in a single clinical center[J]. Langenbecks Arch Surg, 2006, 391(6): 581-587.
[26] Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma[J]. N Engl J Med, 2008, 359(4): 378-390.
[27] Burroughs A, Hochhauser D, Meyer T. Systemic treatment and liver transplantation for hepatocellular carcinoma: two ends of the therapeutic spectrum[J]. Lancet Oncol, 2004, 5(7): 409-418.
[28] Breous E, Thimme R. Potential of immunotherapy for hepatocellular carcinoma[J]. J Hepatol, 2011, 54(4): 830-834.
[29] Gao Q, Wang XY, Qiu SJ, et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carcinoma.[J]. Clin Cancer Res, 2009, 15(3): 971-979.
[30] Hou YF, Wei YG, Yang JY, et al. Combined hepatectomy and radiofrequency ablation versus TACE in improving survival of patients with unresectable BCLC stage B HCC[J]. Hepatobiliary Pancreat Dis Int, 2016, 15(4): 378-385.

多维度评价

Viewed

Full text

Abstract

Cited

Shared

Discussed